The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients

被引:134
作者
Tan, EK
Shen, H
Tan, LCS
Farrer, A
Yew, K
Chua, E
Jamora, RD
Puvan, K
Puong, KY
Zhao, Y
Pavanni, R
Wong, MC
Yih, Y
Skipper, L
Liu, JJ
机构
[1] Singapore Gen Hosp, Dept Neurol, Singapore 0316, Singapore
[2] SingHlth, Div Res, Singapore, Singapore
[3] Natl Inst Neurosci, Singapore, Singapore
[4] Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA
[5] Genome Inst Singapore, Singapore, Singapore
基金
英国医学研究理事会;
关键词
Parkinson's disease; mutation; LRRK2;
D O I
10.1016/j.neulet.2005.04.103
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A common heterozygous leucine-rich repeat kinase 2 (LRRK2) mutation 6055G > A transition (G2019S) accounts for about 3-7% of familial Parkinson's disease (PD) and 1-1.6% sporadic PD in a number of European populations. To determine the prevalence of the G1019S Mutation in our Asian population, we conducted genetic analysis of this mutation in 1000 PD and healthy controls. The G2019S mutation was not detected in any of our study subjects. The prevalence of G2019S mutation is rare (< 0.1 %) in our population, suggesting that occurrence of this mutation may vary amongst different ethnic races. This has important clinical implication when implementing guidelines for genetic testing. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:327 / 329
页数:3
相关论文
共 16 条
[1]   Genetic and environmental risk factors for Parkinson's disease in a Chinese population [J].
Chan, DKY ;
Woo, J ;
Ho, SC ;
Pang, CP ;
Law, LK ;
Ng, PW ;
Hung, WT ;
Kwok, T ;
Hui, E ;
Orr, K ;
Leung, MF ;
Kay, R .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (05) :781-784
[2]  
Di Fonzo A, 2005, LANCET, V365, P412
[3]   Common LRRK2 mutation in idiopathic Parkinson's disease [J].
Gilks, WP ;
Abou-Sleiman, PM ;
Gandhi, S ;
Jain, S ;
Singleton, A ;
Lees, AJ ;
Shaw, K ;
Bhatia, KP ;
Bonifati, V ;
Quinn, NP ;
Lynch, J ;
Healy, DG ;
Holton, JL ;
Revesz, T ;
Wood, NW .
LANCET, 2005, 365 (9457) :415-416
[4]   New aspects of genetic contributions to Parkinson's disease [J].
Hofer, A ;
Gasser, T .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 24 (03) :417-423
[5]   Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations [J].
Kachergus, J ;
Mata, IF ;
Hulihan, M ;
Taylor, JP ;
Lincoln, S ;
Aasly, J ;
Gibson, JM ;
Ross, OA ;
Lynch, T ;
Wiley, J ;
Payami, H ;
Nutt, J ;
Maraganore, DM ;
Czyzewski, K ;
Styczynska, M ;
Wszolek, ZK ;
Farrer, MJ ;
Toft, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (04) :672-680
[6]   Epidemiology versus generics in Parkinson's disease: Progress in resolving an age-old debate [J].
Langston, JW .
ANNALS OF NEUROLOGY, 1998, 44 (03) :S45-S52
[7]   MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese -: art. no. e60 [J].
Lee, CGL ;
Tang, K ;
Cheung, YB ;
Wong, LP ;
Tan, C ;
Shen, H ;
Zhao, Y ;
Pavanni, R ;
Lee, EJD ;
Wong, MC ;
Chong, SS ;
Tan, EK .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (05)
[8]   The G2019SLRRK2 mutation in autosomal dominant European and North African Parkinson's disease is frequent and its penetrance is age-dependant [J].
Lesage, S ;
Ibanez, P ;
Lohmann, E ;
Agid, Y ;
Dürr, A ;
Brice, A .
NEUROLOGY, 2005, 64 (10) :1826-1826
[9]   Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease [J].
Nichols, WC ;
Pankratz, N ;
Hernandez, D ;
Paisán-Ruíz, C ;
Jain, S ;
Halter, CA ;
Michaels, VE ;
Reed, T ;
Rudolph, A ;
Shults, CW ;
Singleton, A ;
Foroud, T .
LANCET, 2005, 365 (9457) :410-412
[10]   Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease [J].
Paisán-Ruíz, C ;
Jain, S ;
Evans, EW ;
Gilks, WP ;
Simón, J ;
van der Brug, M ;
de Munain, AL ;
Aparicio, S ;
Gil, AM ;
Khan, N ;
Johnson, J ;
Martinez, JR ;
Nicholl, D ;
Carrera, IM ;
Pena, AS ;
de Silva, R ;
Lees, A ;
Martí-Massó, JF ;
Pérez-Tur, J ;
Wood, NW ;
Singleton, AB .
NEURON, 2004, 44 (04) :595-600